LE ANSELMINO; BAGLIONI MV; REYNOSO G,; ROZADOS, VIVIANA R.;; O. GRACIELA SCHAROVSKY,; MARÍA JOSÉ RICO; MA MENACHO-MÁRQUEZ

Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers

Scientific Reports; Lugar: Londres; Año: 2023

LE ANSELMINO; MV BAGLIONI; MALIZIA F; N CESATTI LALUCE; C BORINI ETICHETTI; VL MARTÍNEZ MARIGNAC; V ROZADOS,; OG SCHAROVSKY; J GIRARDINI; MJ RICO; M MENACHO MÁRQUEZ

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment

Scientific Reports; Año: 2021

MARTINEZ-AMEZAGA, MAITENA; GIORDANO, ROCÍO A.; PRADA GORI, DENIS N.; PERMINGEAT SQUIZATTO, CATERINA; GIOLITO, MARÍA V.; SCHAROVSKY, O. GRACIELA; ROZADOS, VIVIANA R.; RICO, MARÍA J.; MATA, ERNESTO G.; DELPICCOLO, CARINA M. L.

Synthesis of propargylamines via the A 3 multicomponent reaction and their biological evaluation as potential anticancer agents

ORGANIC & BIOMOLECULAR CHEMISTRY; Año: 2020 vol. 18 p. 2475 - 2486

ANTONELA DEL GIÚDICE,; LUCAS PAGURA,; MARÍA CELESTE CAPITANI,; LE MAINETTI; OG SCHAROVSKY.; RJ DI MASSO; MARÍA JOSÉ RICO; VR ROZADOS

NON-CLASSICAL ROLES FOR IFN-γ AND IL-10 IN A MURINE MODEL OF IMMUNOEDITION

Future Science; Año: 2020

MAINETTI LEANDRO E; MARÍA JOSÉ RICO; KAUFMAN CD; GRILLO MC; GUERCETTI J, ; BAGLIONI MV; DEL GIÚDICE A; CAPITANI MC; FUSSINI M; ROZADOS VR ; SCHAROVSKY OG

Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models

Oncotarget; Año: 2020 vol. 11 p. 3048 - 3060

GIOLITO MV; CAMACHO CM; MARTINEZ-AMEZAGA M, ; TRAFICANTE CI; GIORDANO RA, ; CORNIER PG; DELPICCOLO CML, ; BOGGIÁN, DB, ; DEL GIÚDICE A, ; MAINETTI LE, ; SCHAROVSKY OG, ; ROZADOS VR, ; RICO MJ

ANTITUMOR ACTIVITY OF NEW CHEMICAL AGENTS IN TRIPLE NEGATIVE MAMMARY ADENOCARCINOMA MODELS

Future Science OA; Año: 2020

SCHAROVSKY, O. GRACIELA; JOSÉ RICO, MARÍA; MAINETTI, LEANDRO E.; PERROUD, HERMAN A.; ROZADOS, VIVIANA R.

Achievements and challenges in the use of metronomics for the treatment of breast cancer

BIOCHEMICAL PHARMACOLOGY; Año: 2020

GIOLITO MV; CAMACHO CM; MARTINEZ-AMEZAGA M, ; TRAFICANTE CI; GIORDANO RA, ; CORNIER PG; DELPICCOLO CML, ; BOGGIÁN, DB, ; DEL GIÚDICE A, ; MAINETTI LE, ; SCHAROVSKY OG, ; ROZADOS VR, ; RICO MJ

ANTITUMOR ACTIVITY OF NEW CHEMICAL AGENTS IN TRIPLE NEGATIVE MAMMARY ADENOCARCINOMA MODELS

Future Science OA; Año: 2019

JUAN I. PESOA; MARÍA JOSÉ RICO; ROZADOS VR; SCHAROVSKY, O. GRACIELA;; LUNA JULIO; MENGATO L

Paclitaxel delivery system based on poly(lactide-coglycolide) microparticles and chitosan thermo-sensitive gel for mammary adenocarcinoma treatment

JOURNAL OF PHARMACY AND PHARMACOLOGY; Año: 2018

HA PERROUD; O.G. SCHAROVSKY; VR ROZADOS; CM ALASINO

Clinical Response in Patients with Ovarian Cancer Treated with Metyronomic Chemotherapy

Ecancer medical science; Año: 2017

MARÍA JOSÉ RICO; HERRERA CINTIA; HA PERROUD; ALASINO CM; EA ROGGERO,; PEZZOTTO SM; AL. NOCITO; VR ROZADOS; OG SCHAROVSKY.

Putative biomarkers of response to treatment in breast cancer patients. Pilot assay.

CANCER INVESTIGATION; Lugar: Londres; Año: 2017

BHOL LUCIANA; SOLANGE GUIZZARDI; VALERIA RODRÍGUEZ; LUCILA HINRICHSEN; VIVIANA ROZADOS; DAVID CREMONEZZI; NORI TOLOSA DE TALAMONI ; GABRIELA PICOTTO

COMBINED CALCITRIOL AND MENADIONE REDUCES EXPERIMENTAL MURINE TRIPLE NEGATIVE BREAST TUMOR

BIOMEDICINE & PHARMACOTHERAPY = BIOMEDECINE & PHARMACOTHERAPIE.; Lugar: Paris; Año: 2017

MARÍA RICO; MARÍA BAGLIONI; MARYNA BONDARENKO; NAHUEL CESATTI LALUCE; VIVIANA ROZADOS; NICOLAS ANDRÉ; MANON CARRÉ; O. GRACIELA SCHAROVSKY; MA MENACHO-MÁRQUEZ

Metformin and Popranolol combination prevents cancer progression and metastasis in different breast cancer models

Oncotarget; Año: 2016

PERROUD, H.A; RICO M.J.; C. M. ALASINO; STELLA M. PEZZOTTO; ROZADOS VR; O.G. SCHAROVSKY

Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy

FUTURE ONCOLOGY; Lugar: Londres; Año: 2016

ADRIANA ROSÉ; NICOLAS ANDRÉ; MARÍA J. RICO, LEANDRO E. MAINETTI, HERMAN A. PERROUD, VIVIANA R. ROZADOS, O. GRACIELA SCHAROVSKY; LEANDRO E MAINETTI; MAURICIO MENACHO MÁRQUEZ; MARÍA JOSÉ RICO; PAULA SCHAIQUEVICH; MILENA VILLARROEL; LAURO GREGIANIN; JAUME MORA GRAUPERA; WENDY GÓMEZ GARCÍA; SIDNEI EPELMAN; CARLOS ALASINO; DANIEL ALONSO; GUILLERMO CHANTADA; O GRACIELA SCHAROVSKY

Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27?28 May, 2016, Rosario, Argentina

ecancermedicalscience; Lugar: Londres; Año: 2016

CÁCERES JUAN MANUEL; PAGURA LUCAS ; DI MASSO RJ; RICO MARÍA JOSÉ; ROZADOS VR

Análsis mendeliano de la resistencia/susceptibilidad a un tumor trasnplantable de mama en un modelo murino

Basic and Applied Genetics; Lugar: Buenos Aires; Año: 2015 vol. XXVI p. 83 - 95

HA PERROUD; RICO MARÍA JOSÉ ; ALASINO CM; PEZZOTTO SM; VR ROZADOS; OG SCHAROVSKY

Metastatic breast cancer patients treated with low dose metronomic chemotherapy with cyclophosphamide and celecoxib. Clinical outcomes and biomarkers of response

CANCER CHEMOTHERAPY AND PHARMACOLOGY; Lugar: Berlin; Año: 2015

HA PERROUD; RICO MARÍA JOSÉ ; ALASINO CM; PEZZOTTO SM; VR ROZADOS; OG SCHAROVSKY

METRONOMIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE AND CELECOXIB IN BREAST CANCER PATIENTS PROGRESSING AFTER STANDARD CHEMOTHERAPY. PHASE I/II TRIAL

CANCER CHEMOTHERAPY AND PHARMACOLOGY; Lugar: Berlin; Año: 2015

PAGURA LUCAS; JM CÁCERES; A CARDINALE; O. G. SCHAROVSKY; R. J. DI MASSO; M.F. ZACARÍAS- FLUCK; M. J. RICO; VR ROZADOS

A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting

JOURNAL OF BIOMEDICAL SCIENCE; Lugar: Londres; Año: 2014 vol. 21 p. 1 - 5

MJ RICO; HA PERROUD; LE MAINETTI; VR ROZADOS; OG SCHAROVSKY

Comparative effectiveness of two metronomic chemotherapy schedules. Our experience in the preclinical field

CANCER INVESTIGATION; Año: 2014 vol. 32 p. 92 - 98

MAINETTI LE.; RICO MJ; FERNÁNDEZ ZENOBI MV; PERROUD HA; ROGGERO EA; ROZADOS VR; SCHAROVSKY OG

Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas

ANNALS OF ONCOLOGY; Año: 2013 p. 1 - 7

HERMAN A PERROUD, MARIA JOSÉ RICO, CARLOS M ALASINO, FRANCISCO QUERALT, LEANDRO E MAINETTI, STELLA M PEZZOTTO, VIVIANA R ROZADOS, O GRACIELA SCHAROVSKY; MARIA JOSÉ RICO,; CARLOS M ALASINO; FRANCISCO QUERALT; LEANDRO E MAINETTI,; STELLA M PEZZOTTO; VIVIANA R ROZADOS; O GRACIELA SCHAROVSKY

Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients

FUTURE ONCOLOGY; Lugar: Londres; Año: 2013 vol. 93 p. 451 - 462

PERROUD HA; RICO MJ; ALASINO CM; PEZZOTTO SM; ROZADOS VR; SCHAROVSKYOG

Association between baseline VEGF/SVEGFR 2 and VEGF/TSP 1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer

INDIAN JOURNAL OF CANCER; Año: 2013 vol. 50 p. 115 - 121

MJ RICO; VR ROZADOS; LE MAINETTI; MF ZACARÍAS FLUCK; P MATAR ; O. G SCHAROVSKY

Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model.

Experimental Oncology; Año: 2012 vol. 34 p. 38 - 42

OG SCHAROVSKY; MATAR P; VR ROZADOS; MJ RICO; MF ZACARÍAS FLUCK,; LE MAINETT; MV FERNANDEZ ZENOBI; EA ROGGERO; SI GERVASONI; A ROSSA; HA PERROUD; AM SÁNCHEZ; GC CELORIA; MT FONT

Inmunomodulacion y antiangiogenesis en la terapeutica oncológica de la investigación basica a la clinica

MEDICINA (BUENOS AIRES); Año: 2012 vol. 72 p. 47 - 57

MAINETTI LE.; VR ROZADOS; ROSSA ANA,; BONFIL R.D; SCHAROVSKY OG

Antitumoral and antimetastatic effects of metronomic chemotherapy with cyclophosphamide combined with celecoxib on murine mammary adenocarcinomas

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; Lugar: Berlin; Año: 2010 vol. 151 p. 151 - 163

VR ROZADOS.; LE MAINETTI; MJ RICO; MF ZACARÍAS FLUCK; P MATAR,; OG SCHAROVSKY

The immune response and the therapeutic effect of metronomic chemotherapy with cyclophosphamide

ONCOLOGY RESEARCH; Año: 2010 vol. 18 p. 601 - 605

OG SCHAROVSKY PHD, LE MAINETTI MSC, VR ROZADOS PHD.

Metronomic chemotherapy changing the paradigm that more is better.

CURRENT ONCOLOGY; Año: 2009 p. 7 - 5

P MATAR, L ALANIZ, VR ROZADOS, JB AQUINO, M MALVICINI, C ATORRASAGASTI, M GIDEKEL, M SILVA, OG SCHAROVSKY AND G MAZZOLINI

Immunotherapy for liver tumors: present status and future prospects

JOURNAL OF BIOMEDICAL SCIENCE; Año: 2009 p. 0 - 0

OG SCHAROVSKY PHD. ; LE MAINETTI MSC; VR ROZADOS PHD

Metronomic chemotherapy changing the paradigm that more is better.

CURRENT ONCOLOGY; Año: 2009 p. 7 - 15

P MATAR.; L ALANIZ; VR ROZADOS; JB AQUINO; M MALVICINI; C ATORRASAGASTI; M GIDEKEL; M SILVA; OG SCHAROVSKY; G MAZZOLINI

Immunotherapy for liver tumors: present status and future prospects

JOURNAL OF BIOMEDICAL SCIENCE; Lugar: Londres; Año: 2009 p. 1 - 18

M MALVICINI. ; M RIZZO; L ALANIZ; F PIÑERO; M GARCÍA; C ATORRASAGASTI; JB AQUINO; VR ROZADOS; OG SCHAROVSKY; P MATAR; G MAZZOLINI

A novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice.

CLINICAL CANCER RESEARCH; Lugar: Philadelphia; Año: 2009 vol. 15 p. 7256 - 7265

VR ROZADOS.; LI. HINRICHSEN; MM BINDA; SI GERVASONI; P MATAR; RD BONFILAND; OG SCHAROVSKY

Lovastatin enhances the antitumoral and apoptotic activity of doxorubicin in murine tumor models

ONCOLOGY REPORTS; Lugar: Atenas; Año: 2008 vol. 19 p. 1205 - 1211

VR ROZADOS, LI HINRICHSEN, J MCDONNELL, OG SCHAROVSKY

Lovastatin enhances in vitro radiation-induced apoptosis of rat B-cell lymphoma cells

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH : CR.; Año: 2005 vol. 24 p. 55 - 61

VR ROZADOS, N, , ; LI HINRICHSEN.; J MCDONNELL; OG SCHAROVSKY.

Lovastatin enhances in vitro radiation-induced apoptosis of rat B-cell lymphoma cells

JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH; Lugar: Londres; Año: 2005 vol. 24 p. 55 - 61

OG SCHAROVSKY, MM BINDA, VR ROZADOS, SBL MICHAEL L, CHER, RD BONFIL.

Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance.

Clin & Exp Metastasis; Año: 2004 p. 177 - 183

OG SCHAROVSKY.; MM BINDA; VR ROZADOS; SBL MICHAEL L; CHER ML; RD BONFIL.

Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance.

CLINICAL & EXPERIMENTAL METASTASIS; Año: 2004 vol. 21 p. 177 - 183

VR ROZADOS ; AM SÁNCHEZ; SI GERVASONI; HH BERRA,; P MATAR; O GRACIELA SCHAROVSKY

Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regresion, and is devoid or toxicity

ANNALS OF ONCOLOGY; Año: 2004 vol. 15 p. 1543 - 1550

DR CIOCCA.; VR ROZADOS; FD CUELLO; SI GERVASONI.; PMATAR; OG SCHAROVSKY.

Hsp25 y Hsp70 in rodent tumors treated with doxorubicin and lovastatin

Cell Stress & Chaperones; Año: 2003 p. 26 - 36

MM BINDA, , , , ; P MATAR,; AD GONZÁLEZ; VR ROZADOS; SI GERVASONI,; OG SCHAROVSKY; RD BONFIL

Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells

Int J Cancer; Año: 2002 p. 14 - 21

P MATAR, ; VR ROZADOS,; SI GERVASONI,; OG SCHAROVSKY

Th2/Th1 switch induced by a single-low dose Cyclophosphamide in a rat metastatic lymphoma model

CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 2002 p. 586 - 588

• P MATAR, VR ROZADOS, SI GERVASONI, OG SCHAROVSKY

Th2/Th1 switch induced by a single-low dose Cyclophosphamide in a rat metastatic lymphoma model

CANCER IMMUNOLOGY IMMUNOTHERAPY; Lugar: Berlin; Año: 2002 vol. 50 p. 588 - 596

GA RABINOVICH; N RUBINSTEIN; P MATAR; VR ROZADOS; SI GERVASONI; OG SCHAROVSKY

The antimetastatic effect of a single low-dose Cyclophosphamide involves modulation of Galectin-1 and Bcl-2 expression.

CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 2002 p. 597 - 603

MM BINDA, ; P MATAR; AD GONZÁLEZ; VR ROZADOS,; SI GERVASONI; OG SCHAROVSKY; RD BONFIL

Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: Nueva York; Año: 2002 vol. 100 p. 14 - 21

P MATAR, , I, ; VR ROZADOS; SI GERVASONI; OG SCHAROVSKY

Down regulation of T-cell derived IL-10 production by low-dose cyclophosphamide treatment in tumor-bearing rats restores in vitro normal lymphoproliferative response.

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY; Lugar: Oxford; Año: 2001 vol. 1 p. 307 - 319

VR ROZADOS; P MATAR; SI GERVASONI; J MCDONNELL,; S KAHL; LI HINRICHSEN; OG SCHAROVSKY

Treatment with Lovastatin enhances the in vitro cytotoxic effect induced by irradation or doxorrubicin in rat lymphoma cell (abstract)

JOURNAL OF CLINICAL ONCOLOGY; Año: 2001 p. 98 - 98

G RABINOVICH ; N RUBINSTEIN,; P MATAR; VR ROZADOS; SI GERVASONI; OG SCHAROVSKY

Single-Low dose Cyclophosphamide modulates Galectyin-1 and Bcl-2 expression in lymphoma bearing rats

SCANDINAVIAN JOURNAL OF IMMUNOLOGY; Lugar: Londres; Año: 2001 p. 573 - 573

VR ROZADOS, MM BINDA, P MATAR, SI GERVASONI, RD BONFIL, OG SCHAROVSKY.

The antineoplastic activity of Lovastatin, a lipid-lowering drug.

CANCER DETECTION AND PREVENTION; Año: 2000 p. 0 - 0

OG SCHAROVSKY.. ; VR ROZADOS; SI GERVASONI; P MATAR

Inhibition of ras oncogene: a novel approach to antineoplastic theraphy.

J Biomed Sci; Año: 2000 p. 292 - 298

P MATAR. ; VR ROZADOS; AD GONZÁLEZ; DA DLUGOVITZKY; DR BONFIL; OG SCHAROVSKY

Mechanism of antimetastatic immunopotentiation by low-dose cyclophosphamide

Eur J Cancer; Año: 2000 p. 1060 - 1066

OG SCHAROVSKY, VR ROZADOS, SI GERVASONI, P MATAR.; VR ROZADOS; MM BINDA; EA ROGGERO; DR BONFIL; OG SCHAROVSKY

Inhibitory effect of lovastatin on spontaneous metastases derived from a rat lymphoma.

CLINICAL & EXPERIMENTAL METASTASIS; Año: 1999 p. 19 - 25

P MATAR, ; VR ROZADOS,; EA ROGGERO,; OG SCHAROVSKY

Lovastatin inhibits tumor growth and metastasis development of a rat fibrosarcoma

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS; Año: 1998 p. 387 - 393

P MATAR. ; VR ROZADOS; EA ROGGERO; RD BONFIL; OG SCHAROVSKY

Modulation of the antimetastatic effect of single low dose of cyclophosphamide on rat lymphoma

TUMOR BIOLOGY; Año: 1998 p. 69 - 76